2018 International Health Congress                             28th - 30th June 2018                                                     

2018 Health Conference speakers

Below are listed our confirmed invited Oxford health conference speakers. Please note these may change at any time.

Professor Barry McCormick, Ph.D., C.B.E.

Professor Barry McCormick, Ph.D., C.B.E. Nuffield Department of Primary Care Health Sciences, University of Oxford

Professor Barry McCormick is the Director of the Centre for Health Service Economics and Organisation. He worked as an economist at Cambridge and was Professor of Economics at the University of Southampton from 1991 to 2002. During this period he published extensively on unemployment, migration, and pensions in various journals. From 2002 to 2010 he was Chief Economist and Director of Analysis in the Department of Health, overseeing analysis on a wide range of issues including waiting time targets, MRSA, and medical wage contracts. His present interests include: conventional issues in healthcare policy such as health care reform, how to drive healthcare quality, analysis of aging and the growth of emergency hospital admissions, why GPs act as ‘gatekeepers’, funding medical education, why healthcare in the US is so much more expensive than in Europe, and how to develop healthcare for deprived communities and `homeless’ persons. 

Professor Ricardo Araya Baltra

Professor Ricardo Araya Baltra Institute of Psychiatry, Psychology, and Neuroscience, King's College London

Ricardo Araya Baltra is Professor of Global Mental Health at the Institute of Psychiatry, Psychology, and Neuroscience and Director of the Centre for Global Mental Health at King’s College London. His field of expertise is in the development and implementation of simple and affordable interventions to treat mental disorders, particularly in resource-poor settings. He has developed a model of care to treat common mental disorders, which has been used and adapted in many settings. Two of these initiatives led to implementation at a large scale. The first test of this model was undertaken in Chile and paved the way to the introduction of the first National Depression Treatment Programme in Primary Care in Chile, which is the largest (proportional to the population) programme of this type in the world. More recently, a successful trial of a primary care-based intervention to help people with common mental disorders in Zimbabwe has been scaled-up to all clinics in Harare. He has worked and continues to work in many other countries, such as Brazil, India, Nigeria, Peru, Lebanon, Guatemala, Colombia, Uganda, Tanzania, and others. 

Professor Rowena Jacobs

Professor Rowena Jacobs University of York

Rowena Jacobs is Professor of Health Economics in the Centre for Health Economics at the University of York. Rowena’s research interests include health policy reforms, incentives and performance measurement of mental health services. She leads an NIHR project on the relationship between primary care quality and outcomes for people with serious mental illness. She also leads DH-funded and Wellcome Trust funded research on contracting and payment for mental health services. She also leads a Health Foundation project on efficiency, cost and quality of mental healthcare provision. She has acted as an adviser to various UK government and other agencies, as well as the World Bank, WHO and OECD on health policy and mental health services.

Professor Heather Cordell

Professor Heather Cordell Newcastle University

Professor Heather Cordell Professor of Statistical Genetics and a Wellcome Senior Research Fellow in the Institute of Genetic Medicine at Newcastle University. Her research are the development and application of statistical methodology to genetic studies of complex disease. Her research team develop statistical methodology to detect and characterise genetic variants contributing to common, complex diseases such as type 1 diabetes, asthma, tuberculosis, renal and cardiovascular diseases.This research spans the realm of both linkage and association analysis, using both family (pedigree) data and data from unrelated cases and controls. The methods developed in her team are applied to, and partly inspired by, the data and questions of interest arising from our collaborations with clinical and biological research colleagues.

Professor David Dunger

Professor David Dunger Department of Paediatriacs, University of Cambridge

David Dunger is Professor of Paediatrics and Director of Research at the Department of Paediatrics at the University of Cambridge.  He is also a Faculty member of the Wellcome Trust-MRC Institute of Metabolic Science and Clinical Lead of the Cambridge Clinical Trials Unit. His particular research interests include the physiological and psychological determinants of glycaemic control in adolescents with Type 1 diabetes. His studies identified a critical role for the growth hormone/insulin-like growth factor 1 axis in determining insulin requirements, glycaemic control and potential risk of early complications during adolescence. Professor Dunger is the recipient of several research awards: Nabarro medal awarded by the IDF; the Research Award of the European Society for Paediatric Endocrinology; Andrea Prader Prize from the European Society for Paediatrics Endocrinology; and the James Spence Medal. He is also a Fellow of the Academy of Medical Science and an NIHR Senior Investigator.

Professor Lennart Blomqvist

Professor Lennart Blomqvist Department of Molecular Medicine and Surgery, Karolinska Institute

Lennart Blomqvist is Professor of Diagnostic Radiology at the Department of Molecular Medicine and Surgery at Karolinska Institute, Stockholm Sweden. He is also Director of Research at the Department of Imaging      and Physiology          at the Karolinska University Hospital. He is specialized in gastrointestinal radiology, with a particular focus and vast experience in magnetic resonance imaging of the pelvis and liver with national and international consultations. He is extensively involved in the development of several multidisciplinary teams and the development of diagnostic programmes in patients with cancer at the Karolinska University Hospital and Sweden in general. He is President of the Swedish Society of Gastrointestinal    and Abdominal Radiology (SFGAR) and Head of the Task Force Imaging in the Personalised Cancer Medicine (PCM) programme at Karolinska as part of Cancer Core Europe (CCE). He has received two awards by the European Congress of Radiology Research and Education Fund and a Hirsch Fellowship stipend for a visiting fellowship at the Sloan Memorial Kettering Cancer Centre in New York.

Professor Peter Taylor

Professor Peter Taylor School of Pharmacology, University College London (UCL)

Peter Taylor is Professor of Microbiology at the School of Pharmacology in University College London. His main research interest involves novel approaches to the treatment of infectious disease. He is particularly interested in opportunities to develop therapeutics that suppress or abrogate the emergence of drug resistant variants by modification of the bacterial phenotype. One aspect involves the investigation of enzymes with therapeutic potential that resolve severe, systemic bacterial infections by stripping away the protective polysaccharide or polypeptide capsule. Professor Taylor, along with colleagues from Prince of Songkla University (Thailand), has been awarded a research fund by the UK Medical Research Council and Thai Science Technology Development Agency for research on infectious diseases in the Thai population. 

Professor Richard Stevens

Professor Richard Stevens University of Oxford

Richard Stevens is Associate Professor in Medical Statistics at the University of Oxford. He is the course director of the MSc in Evidence Based Health Care Medical Statistics, a continuing professional development course for those in full-time clinical practice seeking expertise in medical statistics. His research interests include monitoring chronic diseases, especially diabetes and hypertension, and clinical prediction rules, especially risk scores. Much of my research is with colleagues in the Oxford Centre for Monitoring and Diagnosis (MaDOx) on the monitoring of chronic diseases and on diagnosis and prognosis.

Dr Edward Kelley, PhD

Dr Edward Kelley, PhD Department of Service Delivery and Safety, World Health Organization

Dr Edward Kelley is Director of the Department of Service Delivery and Safety at the World Health Organization. In this role, he leads WHO’s efforts to strengthen the safety, quality, integration and people-centredness of health services globally and is the lead for WHO’s work on strengthening health systems and security. Before joining WHO, he served as Director of the National Healthcare Reports for the U.S. Department of Health and Human Services in the Agency for Healthcare Research and Quality. Dr Kelley also directed the 28-country Health Care Quality Improvement (HCQI) Project of the Organisation for Economic Co-operation and Development (OECD). Prior to this, Dr Kelley served as a Senior Researcher and Quality Assurance Advisor for the USAID-sponsored Quality Assurance Project (QAP) and Partnerships for Health Reform Project Plus (PHRPlus).

University of  Birmingham

Professor Mark Exworthy a Professor of Health Policy and Management at the Health Services Management Centre, University of Birmingham. He  has previously held posts at Southampton University, London School of Economics (LSE), University College London (UCL), Oxford Brookes and Royal Holloway University of London. He was also a Harkness Fellow in health care policy, based at University of California-San Francisco (UCSF) (funded by the Commonwealth Fund of New York). Mark is also currently a Visiting Professor at the University of California-San Francisco. His interests lie on the decentralisation in health care organisations, implementation relating to policies to tackle health inequalities and managerialism in healthcare organisations.

International Health Conference
Powered by Wild Apricot Membership Software